Clinical Trials
6 trialsNCT05067257 2024-03-18
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
Sorrento Therapeutics, Inc.
Phase 2 Suspended
NCT01854229 2023-10-18
Prometra Post-Approval Study
Flowonix Medical
Phase NA Completed
NCT04572776 2021-11-09
Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
Sorrento Therapeutics, Inc.
Phase 3 Withdrawn
NCT00381095 2021-01-20
COPE
Pfizer
Phase 4 Terminated
NCT01291901 2014-08-08
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Diamyd Inc
Phase 2 Completed
NCT00216658 2011-01-24
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
Janssen Pharmaceutical K.K.
Phase 2 Completed